Experimental animal models of hypertension

Journal of the American Society of Hypertension

Volumn 3, Issue 3, 2009, Pages 158-165

  Sarikonda, Kiran V ^a   Watson, Ralph E ^a   Opara, Oluchi C ^a   DiPette, Donald J ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

genetic; mineralocorticoid; renal parenchymal; Renovascular

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RENIN;

DIET; DISEASE MODEL; ENVIRONMENTAL FACTOR; ESSENTIAL HYPERTENSION; GENETIC MODEL; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY ISCHEMIA; KIDNEY MASS; MOLECULAR MODEL; NONHUMAN; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; PRIMARY PREVENTION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; REVIEW; STRESS;

EID: 67349121888     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2009.02.003     Document Type: Review

References (88)

1. Watson R.E., and DiPette D.J. Experimental Models of Hypertension. In: Izzo J.L., Sica D.A., and Black H.R. (Eds). Hypertension Primer: The Essentials of High Blood Pressure. 4th ed. (2008), Lippincott Williams & Wilkins, Philadelphia, Pennsylvania 181-183
2. Lerman L.O., Chade A.R., Sica V., and Napoli C. Animal models of hypertension: an overview. J Lab Clin Med 146 (2005) 160-173
3. Doggrell S.A., and Brown L. Rat models of hypertension, cardiac hypertrophy, and failure. Cardiovasc Res 39 (1998) 89-105
4. Goldblatt H., Lynch J., Hanzal R.F., and Summerville W.W. Studies on experimental hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 59 (1934) 347-379
5. Gavras H., Brunner H.R., Thurston H., and Laragh J.H. Reciprocation of renin dependency with sodium volume dependency in renal hypertension. Science 188 (1975) 1316-1317
6. Liard J.-F., Cowley Jr. A.W., McCaa R.E., McCaa C.S., and Guyton A.C. Renin, aldosterone, body fluid volumes, and the baroreceptor reflex in the development and reversal of Goldblatt hypertension in conscious dogs. Circ Res 34 (1974) 549-560
7. Leenen F.H., de Jong W., and de Wied D. Renal venous and peripheral plasma renin activity in renal hypertension in the rat. Am J Physiol 225 (1973) 1513-1518
8. Vasilev T., Kiprov D., Puchlev A., and Todorova L. Plasma renin activity in patients with renovascular hypertension. Cor Vasa 20 (1978) 35-43
9. Freeman R.H., Davis J.O., Watkins B.E., Stephens G.A., and DeForrest J.M. Effects of continuous converting enzyme blockade on renovascular hypertension in the rat. Am J Physiol Renal Physiol 236 (1979) F21-F24
10. Brunner H.R., Kirshman J.D., Sealey J.E., and Laragh J.H. Hypertension of renal origin: evidence for two different mechanisms. Science 174 (1971) 1344-1346
11. Koletsky S., and Goodsitt A.M. Natural history and pathogenesis of renal ablation hypertension. Arch Pathol 69 (1960) 654-662
12. Ylitalo P., Hepp R., Mohring J., and Gross F. Effects of varying sodium intake on blood pressure and renin-angiotensin system in subtotally nephrectomized rats. J Lab Clin Med 88 (1976) 807-816
13. Chi M.S., Jones A.W., and Freeman R.H. Increased arterial potassium transport in reduced renal mass hypertension of the rat. Proc Soc Exp Biol Med 182 (1986) 229-236
14. Meyer T.W., Anderson S., Rennke H.G., and Brenner B.M. Converting enzyme inhibitor therapy limits progressive glomerular injury in rats with renal insufficiency. Am J Med 79 (1985) 31-36
15. Kanagy N.L., and Fink G.D. Losartan prevents salt-induced hypertension in reduced renal mass rats. J Pharmacol Exp Ther 265 (1993) 1131-1136
16. Kuczera M., Hilgers K.F., Lisson C., Ganten D., Hilgenfeldt U., Ritz E., et al. Local angiotensin formation in hindlimbs of uremic hypertensive and renovascular hypertensive rats. J Hypertens 9 (1991) 41-48
17. Moore S., and Mersereau W.A. Microembolic renal ischemia, hypertension, and nephrosclerosis. Arch Pathol 85 (1968) 623-630
18. Page I.H. A method for producing persistent hypertension by cellophane. Science 89 (1939) 273-274
19. Terris J.M., Berecek K.H., Cohen E.L., Stanley J.C., Whitehouse Jr. W.M., and Bohr D.F. Deoxycorticosterone hypertension in the pig. Clin Sci Mol Med Suppl 3 (1976) 303s-5
20. Zambraski E.J., Ciccone C.D., and Izzo Jr. J.L. The role of the sympathetic nervous system in 2-kidney DOCA-hypertensive Yucatan miniature swine. Clin Exp Hypertens A 8 (1986) 411-424
21. Katholi R.E., Naftilan A.J., and Oparil S. Importance of renal sympathetic tone in the development of DOCA-salt hypertension in the rat. Hypertension 2 (1980) 266-273
22. Mohring J., Mohring B., Petri M., and Haack D. Vasopressor role of ADH in the pathogenesis of malignant DOC hypertension. Am J Physiol Renal Physiol 232 (1977) F260-F269
23. Wilson K.M., Sumners C., Hathaway S., and Fregly M.J. Mineralocorticoids modulate central angiotensin II receptors in rats. Brain Res 382 (1986) 87-96
24. Matsumura Y., Hashimoto N., Taira S., Kuro T., Kitano R., Ohkita M., et al. Different contributions of endothelin-A and endothelin-B Receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats. Hypertension 33 (1999) 759-765
25. Li L., Chu Y., Fink G.D., Engelhardt J.F., Heistad D.D., and Chen A.F. Endothelin-1 stimulates arterial VCAM-1 expression via NADPH oxidase-derived superoxide in mineralocorticoid hypertension. Hypertension 42 (2003) 997-1003
26. Li J.S., Schurch W., and Schiffrin E.L. Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats. Am J Hypertens 9 (1996) 803-811
27. Dahl L.K., Heine M., and Tassinari L. Effects of chronic excess salt ingestion: further demonstration that genetic factors influence the development of hypertension: evidence from experimental hypertension due to cortisone and to adrenal regeneration. J Exp Med 122 (1965) 533-545
28. McCubbin J.W., DeMoura R.S., Page I.H., and Olmsted F. Arterial hypertension elicited by subpressor amounts of angiotensin. Science 149 (1965) 1394-1395
29. Ribeiro M.O., Antunes E., de Nucci G., Lovisolo S.M., and Zatz R. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 20 (1992) 298-303
30. Yamada S.S., Sassaki A.L., Fujihara C.K., Avancini Costa Malheiros D.M., De Nucci G., and Zatz R. Effect of salt intake and inhibitor dose on arterial hypertension and renal injury induced by chronic nitric oxide blockade. Hypertension 27 (1996) 1165-1172
31. Lahera V., Salazar J., Salom M.G., and Romero J.C. Deficient production of nitric oxide induces volume-dependent hypertension. J Hypertens Suppl 10 (1992) S173-S177
32. Zatz R., and Baylis C. Chronic nitric oxide inhibition model six years on. Hypertension 32 (1998) 958-964
33. Smookler H.H., Goebel K.H., Siegel M.I., and Clarke D.E. Hypertensive effects of prolonged auditory, visual, and motion stimulation. Fed Proc 32 (1973) 2105-2110
34. Coste S.C., Qi Y., Brooks V.L., McCarron D.A., and Hatton D.C. Captopril and stress-induced hypertension in the borderline hypertensive rat. J Hypertens 13 (1995) 1391-1398
35. Kaufman L.N., Peterson M.M., and Smith S.M. Hypertension and sympathetic hyperactivity induced in rats by high-fat or glucose diets. Am J Physiol 260 (1991) E95-E100
36. Hwang I.S., Ho H., Hoffman B.B., and Reaven G.M. Fructose-induced insulin resistance and hypertension in rats. Hypertension 10 (1987) 512-516
37. Fregly M.J. Effects of extremes of temperature on hypertensive rats. Am J Physiol 176 (1954) 275-281
38. Donaldson G.C., Robinson D., and Allaway S.L. An analysis of arterial disease mortality and BUPA health screening data in men, in relation to outdoor temperature. Clin Sci (Lond) 92 (1997) 261-268
39. Brennan P.J., Greenberg G., Miall W.E., and Thompson S.G. Seasonal variation in arterial blood pressure. Br Med J (Clin Res Ed) 285 (1982) 919-923
40. Papanek P.E., Wood C.E., and Fregly M.J. Role of the sympathetic nervous system in cold-induced hypertension in rats. J Appl Physiol 71 (1991) 300-306
41. Sun Z., Cade R., Zhang Z., and Alouidor J. van H. Angiotensinogen gene knockout delays and attenuates cold-induced hypertension. Hypertension 41 (2003) 322-327
42. Sun Z., Cade R., and Morales C. Role of central angiotensin II receptors in cold-induced hypertension. Am J Hypertens 15 (2002) 85-92
43. Shechtman O., Fregly M.J., van Bergen P., and Papanek P.E. Prevention of cold-induced increase in blood pressure of rats by captopril. Hypertension 17 (1991) 763-770
44. Okamoto K., and Aoki K. Development of a strain of spontaneously hypertensive rats. Jpn Circ J 27 (1963) 282-293
45. Okamoto K., Yamamoto K., Morita N., Ohta Y., Chikugo T., Higashizawa T., et al. Establishment and use of the M strain of stroke-prone spontaneously hypertensive rat. J Hypertens Suppl 4 (1986) S21-S24
46. Trippodo N.C., and Frohlich E.D. Similarities of genetic (spontaneous) hypertension. Man and rat. Circ Res 48 (1981) 309-319
47. Mann J.F., Phillips M.I., Dietz R., Haebara H., and Ganten D. Effects of central and peripheral angiotensin blockade in hypertensive rats. Am J Physiol Heart Circ Physiol 234 (1978) H629-H637
48. DePasquale M.J., Fossa A.A., Holt W.F., and Mangiapane M.L. Central DuP 753 does not lower blood pressure in spontaneously hypertensive rats. Hypertension 19 (1992) 668-671
49. Fortepiani L.A., Yanes L., Zhang H., Racusen L.C., and Reckelhoff J.F. Role of androgens in mediating renal injury in aging SHR. Hypertension 42 (2003) 952-955
50. Bagby S.P., McDonald W.J., and Mass R.D. Serial renin-angiotensin studies in spontaneously hypertensive and Wistar-Kyoto normotensive rats. Transition from normal- to high-renin status during the established phase of spontaneous hypertension. Hypertension 1 (1979) 347-354
51. Kurtz T.W., and Morris Jr. R.C. Biological variability in Wistar-Kyoto rats. Implications for research with the spontaneously hypertensive rat. Hypertension 10 (1987) 127-131
52. St. Lezin E., Simonet L., Pravenec M., and Kurtz T.W. Hypertensive strains and normotensive 'control' strains. How closely are they related?. Hypertension 19 (1992) 419-424
53. Johnson M.L., Ely D.L., and Turner M.E. Genetic divergence between the Wistar-Kyoto rat and the spontaneously hypertensive rat. Hypertension 19 (1992) 425-427
54. Tobian L., Lange J.M., Ulm K.M., Wold L.J., and Iwai J. Potassium prevents death from strokes in hypertensive rats without lowering blood pressure. J Hypertens Suppl 2 (1984) S363-S366
55. Mashimo T., Nabika T., Matsumoto C., Tamada T., Ueno K., Sawamura M., et al. Aging and salt-loading modulate blood pressure QTLs in rats. Am J Hypertens 12 (1999) 1098-1104
56. Rapp J.P., and Dene H. Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats. Hypertension 7 (1985) 340-349
57. Deng Y., and Rapp J.P. Cosegregation of blood pressure with angiotensin converting enzyme and atrial natriuretic peptide receptor genes using Dahl salt-sensitive rats. Nat Genet 1 (1992) 267-272
58. Smirk F.H., and Hall W.H. Inherited hypertension in rats. Nature 182 (1958) 727-728
59. Ben-Ishay D., Saliternik R., and Welner A. Separation of two strains of rats with inbred dissimilar sensitivity to DOCA-salt hypertension. Experientia 28 (1972) 1321-1322
60. Dupont J., Dupont J.C., Froment A., Milon H., and Vincent M. Selection of three strains of rats with spontaneously different levels of blood pressure. Biomedicine 19 (1973) 36-41
61. Sassard J., Lo M., and Liu K.L. Lyon genetically hypertensive rats: an animal model of "low-renin hypertension.". Acta Pharmacol Sin 24 (2003) 1-6
62. Kuijpers M.H., and Gruys E. Spontaneous hypertension and hypertensive renal disease in the fawn-hooded rat. Br J Exp Pathol 65 (1984) 181-190
63. Dobrian A.D., Davies M.J., Prewitt R.L., and Lauterio T.J. Development of hypertension in a rat model of diet-induced obesity. Hypertension 35 (2000) 1009-1015
64. Alonso-Galicia M., Brands M.W., Zappe D.H., and Hall J.E. Hypertension in obese Zucker rats: role of angiotensin II and adrenergic activity. Hypertension 28 (1996) 1047-1054
65. Yamakawa T., Tanaka S.-I., Tamura K., Isoda F., Ukawa K., Yamakura Y., et al. Wistar fatty rat is obese and spontaneously hypertensive. Hypertension 25 (1995) 146-150
66. Sutherland D.J., Ruse J.L., and Laidlaw J.C. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can Med Assoc J 95 (1966) 1109-1119
67. Geller D.S., Farhi A., Pinkerton N., Fradley M., Moritz M., Spitzer A., et al. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 289 (2000) 119-123
68. Hanukoglu A. Type I pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects. J Clin Endocrinol Metab 73 (1991) 936-944
69. Shimkets R.A., Warnock D.G., Bositis C.M., Nelson-Williams C., Hansson J.H., Schambelan M., et al. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 79 (1994) 407-414
70. Simon D.B., Nelson-Williams C., Bia M.J., Ellison D., Karet F.E., Molina A.M., et al. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 12 (1996) 24-30
71. Mansfield T.A., Simon D.B., Farfel Z., Bia M., Tucci J.R., Lebe M., et al. Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21. Nat Genet 16 (1997) 202-205
72. Schuster H., Wienker T.F., Bahring S., Bilginturan N., Toka H.R., Neitzel H., et al. Severe autosomal dominant hypertension and brachydactyly in a unique Turkish kindred maps to human chromosome 12. Nat Genet 13 (1996) 98-100
73. Mullins L.J., Bailey M.A., and Mullins J.J. Hypertension, kidney, and transgenics: a fresh perspective. Physiol Rev 86 (2006) 709-746
74. Hatada S., Kuziel W., Smithies O., and Maeda N. The influence of chromosomal location on the expression of two transgenes in mice. J Biol Chem 274 (1999) 948-955
75. Mullins J.J., Peters J., and Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344 (1990) 541-544
76. Montgomery H.E., Kiernan L.A., Whitworth C.E., Fleming S., Unger T., Gohlke P., et al. Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN2)27. J Hypertens 16 (1998) 635-643
77. Sigmund C.D., Jones C.A., Kane C.M., Wu C., Lang J.A., and Gross K.W. Regulated tissue- and cell-specific expression of the human renin gene in transgenic mice. Circ Res 70 (1992) 1070-1079
78. Yang G., and Sigmund C.D. Developmental expression of human angiotensinogen in transgenic mice. Am J Physiol 274 (1998) F932-F939
79. Fukamizu A., Sugimura K., Takimoto E., Sugiyama F., Seo M.S., Takahashi S., et al. Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J Biol Chem 268 (1993) 11617-11621
80. Rapp J.P., and Deng A.Y. Detection and positional cloning of blood pressure quantitative trait loci: is it possible? Identifying the genes for genetic hypertension. Hypertension 25 (1995) 1121-1128
81. Nadeau J.H., Singer J.B., Matin A., and Lander E.S. Analysing complex genetic traits with chromosome substitution strains. Nat Genet 24 (2000) 221-225
82. Lande R., and Thompson R. Efficiency of marker-assisted selection in the improvement of quantitative traits. Genetics 124 (1990) 743-756
83. Cowley A.W., Liang M., Roman R.J., Greene A.S., and Jacob H.J. Consomic rat model systems for physiological genomics. Acta Physiol Scand 181 (2004) 585-592
84. Esther Jr. C.R., Howard T.E., Marino E.M., Goddard J.M., Capecchi M.R., and Bernstein K.E. Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest 74 (1996) 953-965
85. Sugaya T., Nishimatsu S., Tanimoto K., Takimoto E., Yamagishi T., Imamura K., et al. Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem 270 (1995) 18719-18722
86. John S.W., Krege J.H., Oliver P.M., Hagaman J.R., Hodgin J.B., Pang S.C., et al. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267 (1995) 679-681
87. Shesely E.G., Maeda N., Kim H.S., Desai K.M., Krege J.H., Laubach V.E., et al. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 93 (1996) 13176-13181
88. Williams S.M., Haines J.L., and Moore J.H. The use of animal models in the study of complex disease: all else is never equal or why do so many human studies fail to replicate animal findings?. BioEssays 26 (2004) 170-179